We are excited to announce our investment in Kento Health

Kento is making cardiac rehabilitation accessible to the masses

What is cardiac rehabilitation and what is the problem with it?

Cardiac rehab is a medically supervised program designed to improve your cardiovascular health if you have experienced heart attack, heart failure, angioplasty or heart surgery. The benefits of cardiac rehab programs are significant:

• Individuals who attend a full program of 36 sessions have a 47% lower risk of death and a 31% lower risk of heart attack than those who attend only 1 session.

• Health systems save $4,950 USD to $9,200 per person per year of life saved.

• Cardiac rehab participation also reduces hospital readmissions.

Every year in the US alone an estimated 1.3+ million adults with heart disease may qualify for cardiac rehabilitation but it is estimated that only between 3% and 25% of eligible patients start a program let alone complete a program. The reasons are plentiful: limited availability of practitioners in a geographic area, limited hours of availability, and other inconveniences make it difficult for patients to obtain the treatment they require.

The Kento team knows how to solve this problem based on prior experience

The founding team of Max Leca, Mike Furino, and Jonah Davies all previously worked at Dialogue Health and learned how to improve health outcomes using digital-first solutions.

Based on their experience they saw the ability to leverage AI to drive engagement, outcomes, and accessibility.

Kento's unique vision

Through personalized content delivery, adaptive learning, and natural language processing, Kento's AI-powered platform ensures that patients receive tailored education and exercise recommendations, keeping them engaged and motivated.

With predictive analytics, remote monitoring, and real-time feedback, Kento's AI algorithms track progress, identify potential challenges, and intervene proactively to prevent complications. 

Experience a new era of cardiac rehab, where AI enhances personalization, support, and outcomes. 

What is next?

Kento will be live in market with a leading US health system shortly.

N49P x Kento

N49P is thrilled to announce that it co-lead the $3m pre-seed round with Boreal Ventures. We look forward to working with Kento to make cardiac rehab more accessible.

If you want to learn more about the round you can read the press release here or if you want to learn more about Kento you can check them out here.

Share